➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Harvard Business School
McKinsey
Baxter
Express Scripts

Last Updated: October 30, 2020

DrugPatentWatch Database Preview

PEDIAMYCIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Pediamycin patents expire, and when can generic versions of Pediamycin launch?

Pediamycin is a drug marketed by Ross Labs and Arbor Pharms Llc and is included in three NDAs.

The generic ingredient in PEDIAMYCIN is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

Summary for PEDIAMYCIN
Drug patent expirations by year for PEDIAMYCIN

US Patents and Regulatory Information for PEDIAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate GRANULE;ORAL 062305-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate TABLET, CHEWABLE;ORAL 062306-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ross Labs PEDIAMYCIN erythromycin ethylsuccinate SUSPENSION/DROPS;ORAL 062305-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.